Dose Escalation Safety Study of TL32711 in Adults With Refractory Solid Tumors or Lymphoma
Clinical trial NCT00993239 · COMPLETED
Trial details
- NCT number
- NCT00993239
- Sponsor
- TetraLogic Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-11-01
- Primary completion
- 2012-08-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.